With SpaceX and Starlink, Elon Musk controls more than half the world’s rocket launches and thousands of internet satellites. That amounts to immense geopolitical power.
The brain implant company cofounded by Elon Musk filed to trademark the product names Telepathy and Telekinesis. But it turns out that another person had already filed to trademark those names.
“It’s getting out of hand,” one seller says. “They realize the US market is a gold mine.”
“It’s getting out of hand,” one seller says. “They realize the US market is a gold mine.”
xAI’s gas turbines get official approval from Memphis, Tennessee, even as civil rights groups prepare to sue over alleged Clean Air Act violations.
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer genetic data under a change of ownership.
Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing debilitating side effects.
Beyond the jokes about its new shuttle service are serious questions about what it will mean for struggling transit systems, air quality, and congestion.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
Products made in space—and used on Earth—could be a reality in the coming years.